The diagnostic performance of Cr/CysC for sarcopenia and its predictive value on clinical outcomes in hospitalized older patients: a prospective cohort study
Xiangping Tu,Taiping Lin,Li Huang,Tianjiao Tang,Dongmei Xie,Langli Gao,Tingting Jiang,Jirong Yue
DOI: https://doi.org/10.1007/s41999-024-00948-5
2024-02-24
European Geriatric Medicine
Abstract:To compare the diagnostic accuracy of Cr/CysC, SARC-F, SARC-CalF, the combination of Cr/CysC and SARC-CalF, and the Ishii score for sarcopenia and investigate the predictive value of Cr/CysC concerning clinical outcomes in hospitalized older adults. Cr/CysC could effectively detect sarcopenia and predict poor outcomes in hospitalized older adults. A more precise sarcopenia screening may be offered by combining Cr/CysC with SARC-CalF. In our study, the Ishii score may be the most accurate clinical method for detecting sarcopenia. Cr/CysC could be used to screen for sarcopenia and predict poor outcomes in clinical settings. The utilization of the creatinine-to-cystatin C ratio (Cr/CysC) represents an innovative method for predicting sarcopenia. Our objectives encompassed the evaluation of sarcopenia diagnostic accuracy for Cr/CysC, SARC-F, SARC-CalF, the combination of Cr/CysC and SARC-CalF, and the Ishii score, as well as an exploration of the predictive value of Cr/CysC concerning clinical outcomes within hospitalized older individuals. We employed receiver operating characteristic (ROC) curves and calculated areas under the curves (AUCs) to assess the diagnostic accuracy. Furthermore, we applied univariate and multivariate Cox proportional-hazard models to calculate the hazard ratio (HR) and 95% confidence interval (CI) of risk factors affecting prognosis. Our study included 312 participants, comprising 167 men and 145 women, with an average age of 71 years. Among males, the AUCs for Cr/CysC, SARC-F, SARC-CalF, the combination of Cr/CysC and SARC-CalF, and the Ishii score were 0.717 [95% CI 0.642–0.784], 0.669 (95% CI 0.592–0.739), 0.845 (95% CI 0.781–0.896), 0.882 (95% CI 0.823–0.926), and 0.938 (95% CI 0.890–0.969), respectively. In females, the AUCs for Cr/CysC, SARC-F, SARC-CalF, the combination of Cr/CysC and SARC-CalF, and the Ishii score were 0.706 (95% CI 0.625–0.779), 0.631 (95% CI 0.547–0.710), 0.763 (95% CI 0.686–0.830), 0.789 (95% CI 0.714–0.853), and 0.898 (95% CI 0.837–0.942), respectively. After adjusting for age, sex, physical exercise, smoking, drinking, hypertension, coronary heart disease (CHD), chronic obstructive pulmonary disease (COPD), chronic kidney disease (CKD), and cancer, sarcopenia identified by Cr/CysC (adjusted HR = 2.176, 95% CI 1.062–4.460, P = 0.034) was independently associated with poor overall survival in hospitalized older patients. Cr/CysC has satisfactory diagnostic accuracy for sarcopenia diagnosis and predictive value for poor outcomes in hospitalized older patients. The combination of Cr/CysC and SARC-CalF may provide a more accurate screening for sarcopenia and the Ishii score may be the most accurate clinical method for detecting sarcopenia.
geriatrics & gerontology,gerontology